1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Opioids Overview to 2021 - An Assessment of Pain Management and Dependence

Opioids Overview to 2021 - An Assessment of Pain Management and Dependence

  • August 2015
  • -
  • CBR Pharma Insights
  • -
  • 110 pages

Summary

Table of Contents

Search Inside

Opioids Overview to 2021 - An Assessment of Pain Management and Dependence

Summary

GBI Research’s latest report, "Opioids Overview to 2021 - An Assessment of Pain Management and Dependence" discusses the use of opioids as potent analgesics for the treatment of cancer and non-cancer pain and examines the management of opioid dependence in the US, the UK, Germany, Spain, Italy, France, Australia, Japan, India and China.

Analysis pertaining to the prescribed opioid users, treatment patterns, and market revenues confirms that the use of weak opioids has fallen dramatically in most markets, while the use of strong opioids has increased. The total market size in the countries covered in this report was $15.7 billion in 2014, of which the US accounted for the highest share, followed by Japan and Germany. The global prevalence of chronic pain was 20-30% in the same year, although most of the prevalence population received inadequate treatment due to the high potential for opioid abuse or misuse.

The report also discusses each country’s regulatory restrictions, as well as the treatments available for opioid dependence such as withdrawal management, maintenance, and psychosocial support. In addition, it examines dependence treatment settings, trends, and patient referral pathways. Patient access and cost of treatment remain the key barriers to effectively managing opioid dependence in most countries.

Scope

Dosage and treatment regimes for major opioids used in pain management -
- Which opioids are used for opioid-naïve patients and for patients that experience continuous pain but respond well to opioids?
- Which opioids are considered for first-line and second-line treatment?
Management of opioid dependence according to WHO treatment guidelines -
- What are the recommended medications for opioid maintenance, withdrawal, and overdose?
- What are the treatment regimes followed when using various pharmacotherapy drugs?
- What role does psychosocial treatment play?
In-depth country analysis of opioids for pain management, covering pain prevalence, level of opioid use, commonly used opioids, trends, barriers, and rationalization initiatives -
- What is the overall pain prevalence in each country and is it treated adequately?
- To what extent are opioids used to treat pain?
- What are the major opioids used and the key associated trends?
- Why are patients/prescribers often reluctant to use opioids for pain?
- What initiatives have been taken or recommended to facilitate appropriate use of opioids?
Regulatory landscape and guidelines for opioid prescription -
- Which regulatory laws and bodies oversee import, exports, schedules, and controls on opioids in each country?
- Which narcotic guidelines discuss the prescribing authorities and licenses required to possess or prescribe controlled drugs?
In-depth country analysis of treatment for opioid dependence in all countries, covering dependence, substance abuse trends, treatment usage patterns, and patient referral pathways -
- How many drug users receive treatment for opioid dependence?
- What are the medication usage trends in dependence treatment?
- What are the referral pathways for dependent patients?
Use of novel formulations to prevent abuse and address unmet need in pain management -
- How do agonist-antagonist, abuse-resistant, and overdose-reversal formulations aid abuse prevention?
Challenges addressing the unmet need in opioid dependence treatment -
- Which areas need to be improved to address the unmet need in opioid dependence treatment?

Reasons to buy

This report will allow you to -
- Identify users of prescribed opioids and associated revenues through 2021, as well as key pain management trends and the most frequently used opioids in the analyzed countries.
- Determine the drivers and restraints for opioid use in each country, examine patient/prescriber reasons for reluctance to use opioids for pain relief, and the initiatives being taken or recommended to facilitate appropriate use.
- Gain an understanding of the narcotic guidelines and regulations specific to each country, and determine the prescribing authorities and licenses required to posses/prescribe controlled drugs, the maximum length of time for which an opioid can be prescribed, and recent amendments.
- Analyze substance abuse and dependence trends, prescribing authorities, treatment usage patterns, and government funding for opioid dependence by examining the percentage of people receiving treatment for opioid misuse, the percentage of dependents receiving treatment, and usage trends associated with medications.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Nasal Congestion Global Clinical Trials Review, H2, 2016

Nasal Congestion Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Nasal Congestion Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Nasal Congestion Global Clinical Trials Review, H2, 2016" provides an overview of Nasal Congestion ...

Sleep Apnea Global Clinical Trials Review, H2, 2016

Sleep Apnea Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Sleep Apnea Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Sleep Apnea Global Clinical Trials Review, H2, 2016" provides an overview of Sleep Apnea clinical trials ...

Hyperphosphatemia Global Clinical Trials Review, H2, 2016

Hyperphosphatemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Hyperphosphatemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Hyperphosphatemia Global Clinical Trials Review, H2, 2016" provides an overview of Hyperphosphatemia ...


Download Unlimited Documents from Trusted Public Sources

Opioid Market and Digestive System Disorder Statistics in the US

  • April 2017
    20 pages
  • Opioid  

    Digestive Syste...  

  • United States  

View report >

Therapy Market and Targeted Therapy Market in the UK

  • April 2017
    77 pages
  • Therapy  

    Targeted Therap...  

    Digestive Syste...  

  • United Kingdom  

View report >

Therapy Market in the US

  • April 2017
    30 pages
  • Hospital  

  • United States  

View report >

Related Market Segments :

Opioid

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.